Sartorius Stedim Biotech S.A. (56S1)

Profile

https://www.sartorius.com

Sartorius Stedim Biotech S.A. is a leading international provider of innovative equipment and services for the biopharmaceutical industry and life sciences research. The company specializes in single-use technologies, laboratory instruments, consumables, and bioprocess solutions that support the development, quality assurance, and production of biotech medications, vaccines, and therapies, including cell and gene treatments. Key offerings include bioreactor systems like Ambr® and Biostat®, chromatography tools such as BioSMB and CIM® columns, and advanced analytics for process optimization, enabling faster, safer, and more economical manufacturing. Headquartered in Aubagne, France, with production sites in Germany, France, Puerto Rico, and a global network across more than 30 countries, it employs over 10,000 people and generates recurring revenue primarily from sterile single-use products. As part of the Sartorius Group, it holds strong market positions, driven by demographic trends, medical progress, and expansion in North America and Asia, while focusing on sustainability and innovation through acquisitions and partnerships.